Nordicus Partners Corporation has entered into a Stock Purchase and Sale Agreement with the shareholders of Orocidin A/S, a Danish company, acquiring 29,663 shares which represent 5.34% of Orocidin's outstanding capital stock. This transaction, completed on November 12, 2024, resulted in Orocidin becoming a wholly-owned subsidiary of Nordicus Partners Corporation. In exchange, Nordicus issued 200,000 restricted shares of its common stock to the sellers. These shares have not been registered under any securities law and are subjected to certain transfer restrictions.
Names Mentioned: - Nordicus Partners Corporation - Orocidin A/S - Henrik Rouf